Images List Premium Download Classic

Dysfunction

Dysfunction-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Biomarkers of cognitive dysfunction
The Johns Hopkins University
October 12, 2017 - N°20170292963

The present invention relates to the field of cognitive function. More specifically, the present invention provides compositions and methods useful for assessing cognitive dysfunction/function in alzheimer's disease and other diseases of cognition. In one embodiment, the method comprises the steps of (a) reducing heterocomplexes comprising nptx1 and nptx2 present in a biological sample obtained from the patient into nptx1 ...
Cell based therapy for female sexual dysfunction
Creative Medical Technologies, Inc.
October 12, 2017 - N°20170290887

Disclosed are compositions of matter, therapeutic means, and methods of use for the treatment of female sexual dysfunction associated with vasculogenic degeneration. In one embodiment the invention teaches the use of systemic, or localized platelet rich plasma for restoration of vasculogenic responsiveness to neural signals associated with sexual function in females
Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with serm
Endorecherche, Inc.
October 12, 2017 - N°20170290847

Novel methods for prevention, reduction or elimination of the incidence of male androgen deficiency symptoms or diseases including male hypogonadism-associated symptoms and diseases associated with low serum testosterone and/or low dhea or low total androgens in susceptible warm-blooded animals including humans involving administration of an amount of a sex steroid precursor, particularly dehydroepiandrosterone (dhea) and a selective estrogen receptor ...
Dysfunction Patent Pack
Download 289+ patent application PDFs
Dysfunction Patent Applications
Download 289+ Dysfunction-related PDFs
For professional research & prior art discovery
inventor
  • 289+ full patent PDF documents of Dysfunction-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Sphingomyelin liposomes for the treatment of hyperactive bladder disorders
University Of Pittsburgh - Of The Commonwealth System Of Higher Education
October 12, 2017 - N°20170290773

The present invention provides pharmaceutical compositions and methods for the instillation of lipid vehicles comprised of liposomes containing sphingomyelin or sphingomyelin metabolites to prevent, manage, ameliorate and/or treat disorders involving neuropathic pain and aberrant muscle contractions, such as what occurs in bladder hyperactivity disorders such as interstitial cystitis (ic) in animals or humans in need thereof. Also provided is ...
Medical device comprising an artificial contractile structure
Myopowers Medical Technologies France Sas
October 12, 2017 - N°20170290649

A medical device including an artificial contractile structure which may be advantageously used to assist the functioning of a hollow organ. Specifically, the medical device includes an artificial contractile structure with at least one contractile element adapted to contract an organ, in such way that the contractile element is in a resting or in an activated position, at least one ...
Renal dysfunction risk stratification
Cardiac Pacemakers, Inc.
October 12, 2017 - N°20170290551

Systems and methods for assessing a patient's risk of renal dysfunction are described. A system may include sensor circuits to sense physiological signals and processors to generate signal metrics from the physiological signals. The system may generate a primary renal risk indication using a first signal metric, and a secondary renal risk indication using at least a second signal metric. ...
Dysfunction Patent Pack
Download 289+ patent application PDFs
Dysfunction Patent Applications
Download 289+ Dysfunction-related PDFs
For professional research & prior art discovery
inventor
  • 289+ full patent PDF documents of Dysfunction-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Method and system for microbiome-derived diagnostics and therapeutics
Ubiome, Inc.
October 05, 2017 - N°20170286619

A method for diagnosing and treating an immune microbial dysfunction in a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the immune microbial dysfunction based upon features extracted ...
Bispecific antibodies that neutralize both tnf-alpha and il-6: novel therapeutic agent for autoimmune disease
Ibc Pharmaceuticals, Inc.
October 05, 2017 - N°20170283511

The present invention concerns compositions and methods of use of bispecific antibodies comprising at least one anti-tnf-α antibody or antigen-binding fragment thereof and at least one anti-il-6 antibody or antigen-binding fragment thereof. Preferably, the bispecific antibody is in the form of a dnl® complex. The anti-tnf-α or anti-il-6 antibodies may comprise specific cdr sequences disclosed ...
Substituted 1-h-indol-3-yl-benzamide and 1, 1'-biphenyl analogs as histone demethylase inhibitors
University Of Utah Research Foundation
October 05, 2017 - N°20170283397

Substituted 1-h-indol-3-yl-benzamide and 1, 1′-biphenyl analogs derivatives thereof, and related compounds, which are useful as inhibitors of lysine-specific histone demethylase, including lsd1; synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of using the compounds and compositions to treat disorders associated with dysfunction of the lsd1.
Metabolism probes for therapy and diagnosis
Vanderbilt University
October 05, 2017 - N°20170283387

Novel 2-substituted glutamylanides useful as modulators of asct2 inhibitors. Compounds of the present invention can be used to treat patients suffering from diseases caused or influenced by abnormal asct2 transporter dysfunction.
Systems and methods for treating female incontinence and pelvic nerve dysfunction
Parapatch, Inc.
October 05, 2017 - N°20170281939

Systems and methods for neuromodulation of a female patient suffering from a pelvic condition, such as incontinence, are disclosed. A mechanical stimulus such as pressure, tension, traction, friction, or vibration for example can be applied to one, two, or more clitoral structures sufficient to cause a physiologic stimulus or inhibition, such as neuromodulation to treat or prevent the pelvic condition.
A method for side effect reduction in the use of statins via physiologically synthesized glutathione
Parapatch, Inc.
October 05, 2017 - N°20170281713

Embodiments of the present invention relate generally the use of certain compositions, e. G., compositions comprising a glutathione precursor and a selenium source, in the therapy of subjects suffering from diseases associated with hyperiipidemia and/or hypercholesterolemia. Related embodiments of the present invention relate to treatment and/or reducing the incidence of the side effects of statin therapy comprising administering ...
Pyrimidinedione compounds
Myokardia, Inc.
October 05, 2017 - N°20170281626

Provided are novel pyrimidine dione compounds and pharmaceutically acceptable salts thereof, that are useful for the treatment of hypertrophic cardiomyopathy (hcm) and conditions associated with left ventricular hypertrophy or diastolic dysfunction. The synthesis and characterization of the compounds and pharmaceutically acceptable salts thereof, are described, as well as methods for treating hcm and other forms of heart disease.
Dysfunction Patent Pack
Download 289+ patent application PDFs
Dysfunction Patent Applications
Download 289+ Dysfunction-related PDFs
For professional research & prior art discovery
inventor
  • 289+ full patent PDF documents of Dysfunction-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Organ regeneration method utilizing blastocyst complementation
The University Of Tokyo
October 05, 2017 - N°20170280692

An object of the present invention is to produce a mammalian organ having a complicated cellular composition composed of multiple kinds of cells, such as kidney, pancreas, thymus and hair, in the living body of a non-human animal. The inventors of the present invention applied the chimeric animal assay described above, to a novel solid organ production method. More specifically, ...
Humanized anti-cd22 antibody
Immunomedics, Inc.
September 28, 2017 - N°20170275363

Disclosed are humanized rfb4 antibodies or antigen-binding fragments thereof. Therapy of b-cell associated diseases, such as b-cell malignancies, autoimmune disease and immune dysfunction disease. Preferably, hrfb4 comprises the light and heavy chain rfb4 cdr sequences with human antibody fr and constant region sequences, along with heavy chain framework region (fr) amino acid residues q1, f27, v48, a49, f68, r98, t117 ...
Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction
Eb Ip Lybrido B.v.
September 28, 2017 - N°20170273989

The present invention relates to the use of a combination of a pde5-inhibitor and testosterone for the preparation of a medicament for the treatment of female sexual dysfunction.
Minimally invasive implant and method
Astora Women's Health, Llc
September 28, 2017 - N°20170273771

Apparatus and methods are provided for treating urinary incontinence, fecal incontinence, and other pelvic defects or dysfunctions, in both males and females, using one or more lateral implants to reinforce the supportive tissue of the urethra. The implants can be configured as a sling device having at least one extension arm and a tissue support portion having an eyelet, wherein ...
Novel technique for therapeutic contact lens systems
Purdue Research Foundation
September 28, 2017 - N°20170273731

The invention relates to electronic contact lens systems, methods for fabrication thereof, and uses thereof for treatment of ophthalmic diseases and conditions, for example, meibomian gland dysfunction.
Method and system for microbiome-derived diagnostics and therapeutics
Ubiome, Inc.
September 21, 2017 - N°20170270272

A method for diagnosing and treating an immune microbial dysfunction in a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the immune microbial dysfunction based upon features extracted ...
Method and system for microbiome-derived diagnostics and therapeutics
Ubiome, Inc.
September 21, 2017 - N°20170270271

A method for diagnosing and treating an immune microbial dysfunction in a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the immune microbial dysfunction based upon features extracted ...
Method and system for microbiome-derived diagnostics and therapeutics
Ubiome, Inc.
September 21, 2017 - N°20170270270

A method for diagnosing and treating an immune microbial dysfunction in a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the immune microbial dysfunction based upon features extracted ...
Loading